NCT05929209View on ClinicalTrials.gov

Exploring Biomarkers in Hereditary Transthyretin Amyloidosis

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions
Hereditary Transthyretin Amyloidosis
Interventions
DIAGNOSTIC_TEST

Assessment of disease biomarkers

Assessment of serum, histological and radiological biomarkers

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER